Anthropic Valuation Draws VC Offers

Anthropic valuation drew non-binding VC bids as the firm posted rapid revenue growth and potential IPO plans that are reshaping investor positioning.

April 15, 2026·2 min read
View all news articles
Flat filled vector of a chip cluster expanding into stacked model tiles symbolizing Anthropic valuation and IPO plans.

KEY TAKEAWAYS

  • Anthropic had rebuffed non-binding VC bids valuing the company at up to $800 billion.
  • Annualized run-rate revenue reached $30 billion by early April 2026, driven by enterprise demand.
  • Anthropic had explored an IPO that could raise more than $60 billion, reshaping investor comparisons.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Anthropic’s valuation has attracted multiple non-binding venture-capital offers in recent weeks, which the company has declined, as the AI firm accelerates enterprise revenue and prepares for a potential October 2026 IPO following the release of a new model on April 7, 2026.

VC Offers and Valuation

In recent weeks, Anthropic received several non-binding venture-capital bids valuing the company as high as $800 billion. This surpasses the $380 billion post-money valuation from its $30 billion funding round in February 2026, led by GIC and Coatue. These offers reflect a rapid re-pricing of private markets for large-scale AI providers.

Secondary-market trades on Caplight placed Anthropic’s valuation at $688 billion, a 75% increase over three months. This figure remains below the highest private bids, illustrating competing price signals in the market for unlisted AI shares.

The surge in interest has intensified comparisons with OpenAI, which raised $110 billion in March 2026 at an $852 billion post-money valuation. Some OpenAI investors have questioned that valuation and said they would require an IPO price above $1.2 trillion to justify it. OpenAI projects breakeven by 2030 after cumulative losses exceeding $200 billion. Anthropic declined to comment.

Anthropic’s rapid commercial growth has led some investors to reassess the premium previously given to OpenAI, altering internal valuations and fueling competition among deep-pocketed private buyers.

Revenue Growth and IPO Plans

Anthropic’s annualized run-rate revenue reached $30 billion by early April 2026, up from $9 billion at the end of 2025. Intermediate figures showed $14 billion in February and about $19–20 billion in March, driven largely by demand for its Claude Code product. More than 1,000 enterprise customers now each spend over $1 million annually, a group that doubled in fewer than two months and has been central to the company’s growth narrative.

On April 7, 2026, Anthropic unveiled the Claude Mythos model through Project Glasswing. Access to the release has been restricted due to cybersecurity concerns, coinciding with the rise in enterprise demand.

The company is in discussions with Goldman Sachs, JPMorgan, and Morgan Stanley for a potential October 2026 IPO that could raise more than $60 billion and target a pre-IPO valuation near the figure. Anthropic expects to reach positive cash flow by 2028 after cumulative cash burn of about $22 billion.

Anthropic has committed roughly $50 billion to data-center construction, $30 billion to Microsoft cloud contracts, and plans to spend several billion annually on Amazon Web Services. These infrastructure investments highlight the scale of its near-term capital needs and the foundation of its commercial expansion.

These commitments, combined with a shorter path to profitability than some peers, will influence investor scrutiny and pricing debates ahead of any listing.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

SpaceX Starship Launch Abort Scrubs Flight 13

SpaceX Starship Launch Abort Scrubs Flight 13

SpaceX Starship Launch Abort delayed Flight 13 after engine-start failures, raising operational uncertainty that clouds near-term launch cadence.

Alcoa Q2 Results Show Record Revenue, Alumina Cut

Alcoa Q2 Results Show Record Revenue, Alumina Cut

Alcoa Q2 results showed record revenue and higher adjusted profit but missed consensus and cut 2026 alumina guidance, tightening supply expectations.

Netflix Q2 2026 Earnings Cut Viewing Data, Trim Guidance

Netflix Q2 2026 Earnings Cut Viewing Data, Trim Guidance

Netflix Q2 2026 earnings showed a slight revenue miss and below-Street Q3 guidance; cutting viewing-hours reports raises scrutiny of engagement and models.

Merck Lipfendra FDA Approval Expands Portfolio

Merck Lipfendra FDA Approval Expands Portfolio

Merck Lipfendra FDA approval adds the first oral PCSK9 pill to Merck's portfolio and a $315 list price could shape adoption and payer positioning.

Alphabet Q2 2026 Earnings Preview

Alphabet Q2 2026 Earnings Preview

Alphabet Q2 2026 earnings preview sees traders watching Cloud growth and AI monetization as analyst price target raises shape prereport positioning.

SK Hynix Stock Plunge Prompts ETF Curbs

SK Hynix Stock Plunge Prompts ETF Curbs

SK Hynix stock plunge prompted Seoul to tighten single-stock leveraged ETF rules, raising deposit requirements and pausing new listings.